Search

everythinglearnresearchcommunity

for

Search:↓

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

TS-13 speeds up hair regrowth after chemotherapy.

Tyrosine kinase inhibitors for endocrine tumors often cause skin issues, requiring early management and treatment adjustments.

Tofacitinib may be safe and effective for treating certain skin conditions in children.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

Targeting Interleukin-13 could help treat alopecia areata linked with atopic dermatitis.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Ciclosporin can cause excessive hair growth even with testosterone blockers.

Ritlecitinib is effective for long-term hair regrowth in alopecia areata, especially in females and early treatment.

Block and replace therapy improved symptoms in recurrent cyclic Cushing’s disease.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

Aggressive immunosuppressive treatment improved a woman's severe heart condition linked to autoimmune disease.

Hinokitiol may help treat hair loss by reducing inflammation and promoting hair growth.

Early use of infliximab in severe pediatric Crohn's disease can lead to significant improvement and remission.

TLR-targeted therapies show promise in cancer treatment by helping destroy tumors.

Janus kinase inhibitors may effectively treat severe alopecia areata unresponsive to other treatments.

Baricitinib is effective in promoting hair growth in severe alopecia areata.

JAK inhibitors are effective for hair regrowth in severe alopecia areata.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Anti-TNF-α therapy may increase the risk of developing alopecia areata, especially in those with a history of autoimmune disease.

Diphenylcyclopropenone treatment helps hair growth in alopecia areata by promoting blood vessel growth and cell survival.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

Topical tofacitinib shows promise as a future treatment for alopecia areata.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Balancing testosterone may reduce COVID-19 severity.

Alopecia areata treatments should be personalized, using options like steroids, JAK inhibitors, and other therapies based on individual needs.

Janus kinase inhibitors are effective and safe for treating Alopecia Areata.

Ruxolitinib helps regrow hair in alopecia areata by blocking inflammation, reducing stress, and controlling cell death.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.